Last updated 2026-07-24
Total raised
—
Last: Grant 2005-05
Stage
Seed
Founded
2019
Headcount
5
HQ
Ness Ziona, Israel
Sector
Health Tech & Life Sciences
About
Formulex Pharma Innovations is an Israeli formulation and drug-delivery development company established in April 2019. It provides formulation R&D, analytical support, and small-scale GMP production for clinical-stage programs. The company focuses on solubility/bioavailability enhancement and new delivery routes for APIs across biopharma, nutraceutical, and agrochemical applications. Formulex continues the activities of SoluBest Ltd. in the field of nano-technology based drug delivery and formulation, and has developed over 10 medical cannabis products, with five in clinical and commercial stages.
Offices
Ness Ziona, Israel · HQ / main office
Q&A
- What is Formulex Pharma Innovations' primary focus?
- Formulex Pharma Innovations specializes in nanotechnology-based drug delivery and formulation, providing innovative solutions for clients in biopharmaceuticals, nutraceuticals, and agrochemicals.
- How many employees does Formulex Pharma Innovations have?
- Formulex Pharma Innovations has 1-10 employees.
- What is the total amount of funding Formulex Pharma Innovations has raised?
- Formulex Pharma Innovations has raised a total of $55,000,000.
- When was Formulex Pharma Innovations founded?
- Formulex Pharma Innovations was founded in July 2001.
- Does Formulex Pharma Innovations have any patents?
- Yes, Formulex Pharma Innovations holds patents, including for its Solumer technology.
- What is the Solumer technology developed by Formulex Pharma Innovations?
- Solumer is a patented technology developed by Formulex Pharma Innovations (formerly SoluBest) to maximize the solubility, bioavailability, and physical stability of drug substances through sub-micron-particle engineering and proprietary spray drying processes.
- What types of products has Formulex Pharma Innovations developed using its technology?
- Formulex Pharma Innovations has developed over 10 medical cannabis products using its patented Solumer and generic technologies, with five products currently in clinical and commercial stages.
- What dosage forms can Formulex Pharma Innovations develop and produce?
- Formulex Pharma Innovations can develop and produce oral, topical, and inhaled dosage forms under GMP conditions for clinical phases one and two.
Team · 7
Dr. Galia Temtsin Krayz
Founder · Chief Executive Officer and Head of R&D
Anna Vainshtein
Chief Operations Officer
Anna Berman
Head of Analytical Department
Pavel Kazhdan
Chief Technology Officer
Dr. Ronnie Hershman
BOARD MEMBER
Dr. Dalia Meggido
BOARD MEMBER
Udi Gilboa
BOARD MEMBER
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyMedical CannabisDrug Delivery
Technologies
Materials & SubstancesRaw MaterialsBiologicalsMolecules
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B
Highlights
1 Patents
Tags
nanotechnologybiotechnologydrug-designfoodtechpharmaceuticalsanimal-healthoral-drugsmedical-cannabisdrug-delivery
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | formulex-pi.com/ |
|---|---|
| linkedin.com/company/1044256 |
Identifiers & details
| Former names | SoluBest |
|---|---|
| Founded | 2019-4 |
| Employees (exact) | 5 |
Radar intelligence
Patents
| EPO | 3 |
|---|
Web history (Wayback)
| Domain | formulex-pi.com |
|---|
Certificate / subdomain footprint
| Subdomains | 2 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 513125682 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2001-07-01 |
| Purpose | לעסוק בסוגי עיסוק שפורטו בתקנון |
| Liability | מוגבלת |
| In violation (unfiled) | yes |
| Last annual report | 2015 |
| Active charges / liens | 0 |
| Registry events | 0 |
| Registered address | אינשטיין 18 נס ציונה |